Medicine and Dentistry

Blog: Kidney disease is growing in Africa: big new study casts light on genetic risk factors

Segun Fatumo, Professor and Chair of Genomic Diversity at Queen Mary University of London, has written for The Conversation on ‘Kidney disease is growing in Africa: big new study casts light on genetic risk factors.’ 

Largest genomic study of kidney function in Africa reveals new genetic risk factors

An international research collaboration led by Queen Mary University of London and University of the Witwatersrand (Wits) in South Africa has published the most comprehensive genomic investigation of kidney function ever conducted in African populations.  

Queen Mary's Digital Education Studio wins prestigious prize

Queen Mary University of London's Digital Education Studio has been awarded the 2026 Roger Mills Prize – one of the most prestigious honours in digital higher education – for its transformative approach to online learning through the CARE as Value-Led Digital Education Transformation initiative. 

Dr Cara Croft receives Suffrage Science Award for Life Sciences

Dr Cara Croft, Senior Lecturer in Neuroscience at Queen Mary University of London, has been awarded the 2026 Suffrage Science Award for Life Sciences. The prestigious peer-to-peer award recognises outstanding women in science for both research excellence and their commitment to inspiring others.  

Study finds shared genetic roots of MS across diverse ancestries

A new study published in Neurology and led by Queen Mary University of London, has revealed that people of South Asian, African and European ancestry share many of the same genetic risk factors for multiple sclerosis (MS). 

Drug that targets immune cells shows potential as new treatment for diabetic heart disease

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage — not by controlling blood sugar as originally intended, but by retraining the immune system to protect the heart from within. 

Single daily pill shows promise as replacement for complex, multi-tablet HIV treatment regimens

A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral tablet that combines two current HIV treatment medications – bictegravir and lenacapavir (BIC/LEN) – may simplify treatment significantly for people with HIV who currently take very complex treatments.

High-risk patients account for 80% of post-surgery deaths

Large UK-wide study shows that high-risk patients account for nearly 80% of post-surgery deaths, highlighting the need for open conversations and more tailored care.  

Blog: For neighbourhood care to work, we need a shared data infrastructure

Dr Anna De Simoni, Clinical Reader in Primary Care Research at Queen Mary University of London, wrote for the Health Service Journal (HSJ) about what is needed for neighbourhood care to work.

Study sheds new light on early brain development in Down Syndrome

Researchers uncover defects in membrane of brain cells that diminish their action and connectivity during development in Down Syndrome.

Queen Mary research results in changes to NHS guidelines

Thousands of people with advanced bladder cancer across the UK can now receive three rather than six chemotherapy cycles following research by Queen Mary University of London which has led to a change to NHS treatment guidelines. For people with the condition, this means fewer toxic side effects and a better quality of life during treatment.

Celebrating the history of medicine and dentistry at Queen Mary

Queen Mary University of London has a proud 240-year history of improving lives and access to higher education, built on four historic institutions the oldest of which – The London Hospital Medical College – was founded in 1785.

First of its kind daily HIV treatment shows promising results

The daily pill paves the way for other long-acting treatments for those living with HIV, and addresses the growing concern of resistance to integrase strand-transfer inhibitor (INSTI) treatments, which are the first line of treatments for HIV across the world.  

Queen Mary strengthens partnership with Barking and Dagenham Council

The Institute of Dentistry at Queen Mary University of London welcomed several members of the Cabinet from the London Borough of Barking and Dagenham to strengthen the collaboration between the University and Council, following the successful application to provide a dental outreach clinic in Maritime House, Barking. 

New approach offers hope for people with rare eye cancer

Researchers at Queen Mary’s Barts Cancer Institute have found a more active approach to monitoring and treating people with a rare eye cancer (known as uveal melanoma) that has spread to the liver could help some patients to live longer. 

England’s Chief Dental Officer reopens Queen Mary’s refurbished Barkantine Dental Outreach Clinic

Queen Mary University of London welcomed the Chief Dental Officer for England, Jason Wong MBE, and members of the General Dental Council to reopen one of its newly refurbished dental outreach clinics in East London.

Mapping proteins in African genomes reveals new paths to fight type 2 diabetes

By combining genomic and plasma proteomic data from a Ugandan cohort, the researchers mapped nearly 400 genetic regions that regulate circulating protein levels – 58 of them previously unknown in African-ancestry individuals.

Experts provide policy roadmap to reduce dementia risk, the leading cause of death in the UK

A national panel of experts has issued the strongest call yet for the Department of Health and Social Care to overhaul how it approaches dementia prevention, pointing to vital evidence that dementia risk can be reduced and providing a framework for the development of new government policy that could improve brain health for millions.